Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Mucosal Effects of Nicotine Bitartrate vs Polacrilex Lozenges in Smokers
NCT03087786Phase 1Completed
- Sponsor
- British American Tobacco
- Start
- Mar 2017
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of nicotine in nicotine dependence (2 arms), sponsored by British American Tobacco. Primary endpoint: Oral Mucosa Irritation 20 Total Score at Day 21. Started Mar 2017; status: completed.
02
Drugs
nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT03087786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03087786.